421 results on '"Kruchko, Carol"'
Search Results
2. Molecular biomarker-defined brain tumors: Epidemiology, validity, and completeness in the United States.
3. A population study of clinical trial accrual for women and minorities in neuro-oncology following the NIH Revitalization Act.
4. Aligning the Central Brain Tumor Registry of the United States (CBTRUS) histology groupings with current definitions.
5. Mortality trends in primary malignant brain and central nervous system tumors vary by histopathology, age, race, and sex
6. Association Between Urbanicity and Outcomes Among Patients with Spinal Cord Ependymomas in the United States
7. Associations between urbanicity and spinal cord astrocytoma management and outcomes
8. European genetic ancestry associated with risk of childhood ependymoma
9. Changes in survival over time for primary brain and other CNS tumors in the United States, 2004–2017
10. 787 Higher County-Level Socioeconomic Status Is Associated With Increased Meningioma Survival But Does Not Impact Likelihood of Surgical Treatment: A CBTRUS Analysis
11. Brain tumor epidemiology in the era of precision medicine: The 2017 Brain Tumor Epidemiology Consortium meeting report
12. The impact of COVID-19 on 2020 monthly incidence trends of primary brain and other CNS tumors
13. Association of county-level socioeconomic status with meningioma incidence and outcomes
14. Impact of environment on pediatric and adult brain tumors: The 2023 Brain Tumor Epidemiology Consortium meeting report
15. Descriptive epidemiology of craniopharyngiomas in the United States
16. CBTRUS Statistical Report: American Brain Tumor Association & NCI Neuro-Oncology Branch Adolescent and Young Adult Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2016–2020.
17. Association of county-level socioeconomic status with meningioma incidence and outcomes.
18. Association between county-level socioeconomic status and the incidence of and surgical treatment for pituitary adenoma.
19. Geographic and temporal variations in the utilization of stereotactic radiosurgery for treatment of non-small cell lung cancer brain metastases from 2010 to 2015: An analysis of the national cancer database
20. EPID-24. CAPTURING EVOLVING DEFINITIONS OF 12 SELECT RARE CNS TUMORS: A TIMELY REPORT FROM CBTRUS AND NCI-CONNECT
21. NCOG-19. SEX DIFFERENCES IN GLIOBLASTOMA TREATMENT AND ADVERSE EVENTS
22. EPID-28. YEARS OF LIFE LOST FOR BRAIN AND OTHER CENTRAL NERVOUS SYSTEM TUMORS IN THE UNITED STATES, 2018
23. EPID-31. BRAIN TUMORS IN UNITED STATES MILITARY VETERANS
24. EPID-11. THE IMPACT OF THE COVID-19 PANDEMIC ON TREATMENT PATTERNS IN GLIOBLASTOMA
25. CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2016—2020
26. Childhood, adolescent, and adult primary brain and central nervous system tumor statistics for practicing healthcare providers in neuro-oncology, CBTRUS 2015-2019
27. Brain tumors in United States military veterans
28. Primary central nervous system lymphoma in patients with and without HIV infection : a multicenter study and comparison with U.S national data
29. Disparities in the use of stereotactic radiosurgery for the treatment of lung cancer brain metastases: a SEER-Medicare study
30. Childhood, adolescent, and adult primary brain and central nervous system tumor statistics for practicing healthcare providers in neuro-oncology, CBTRUS 2015–2019.
31. Brain tumors in United States military veterans.
32. Association Between Urbanicity and Outcomes Among Patients with Spinal Cord Ependymomas in the United States
33. The impact of the COVID-19 pandemic on treatment patterns in glioblastoma.
34. Partnership for defining the impact of 12 selected rare CNS tumors: a report from the CBTRUS and the NCI-CONNECT
35. Descriptive epidemiology of germ cell tumors of the central nervous system diagnosed in the United States from 2006 to 2015
36. Racial/ethnic differences in survival for patients with gliosarcoma: an analysis of the National cancer database
37. The epidemiology of central and extraventricular neurocytoma in the United States between 2006 and 2014
38. Primary brain and other central nervous system tumors in Appalachia: regional differences in incidence, mortality, and survival
39. Data Matching to Support Analysis of Cancer Epidemiology Among Veterans Compared With Non-Veteran Populations—An Exemplar in Brain Tumors
40. Complete prevalence of primary malignant and non‐malignant brain tumors in comparison to other cancers in the United States
41. The joint impacts of sex and race/ethnicity on incidence of grade 1 versus grades 2–3 meningioma across the lifespan
42. Bevacizumab for the treatment of non-small cell lung cancer patients with synchronous brain metastases
43. The association of Medicaid expansion and pediatric cancer overall survival
44. Pediatric brain tumors: Origins, epidemiology, and classification - The 2022 Brain Tumor Epidemiology Consortium meeting report
45. Medicaid expansion is associated with increased 1-year survival for primary malignant brain tumors
46. Do race and age vary in non-malignant central nervous system tumor incidences in the United States?
47. Corrigendum to: Molecular biomarker-defined brain tumors: Epidemiology, validity, and completeness in the United States
48. Changes in survival over time for primary brain and other CNS tumors in the United States, 2004–2017
49. Complete prevalence of primary malignant and nonmalignant brain tumors in comparison to other cancers in the United States.
50. EPID-20. MORTALITY TRENDS IN PRIMARY MALIGNANT BRAIN AND CENTRAL NERVOUS SYSTEM TUMORS VARY BY HISTOPATHOLOGY, AGE, RACE, AND SEX
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.